Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Journey Medical Corporation (DERM)

BGM Group Ltd. and Journey Medical Corporation are both Drug Manufacturers Specialty & Generic companies. Journey Medical Corporation is the larger, with a market value of $144.7M against $114.7M — 1.3× the size. Journey Medical Corporation has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 144×. BGM Group Ltd. has the higher net margin (1.96% vs −8.95%) and the higher return on invested capital (0.00% vs −5.89%). Across the 15 metrics below, BGM Group Ltd. leads on 10 and Journey Medical Corporation on 5.

Valuation

Metric BGM DERM Drug Manufacturers Specialty & Generic median
P/E 144.17 n/m 19.25
P/S n/m 2.00 2.11
P/B n/m 4.26 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 78.30 12.58
EV/Sales (0.09) 2.00 2.73
Earnings yield 0.69% (4.43%) (4.38%)
Free cash flow yield 0.00% (16.46%) 0.00%

Profitability

Metric BGM DERM Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 65.45% 53.94%
Operating margin 0.00% (4.41%) 0.00%
Net margin 1.96% (8.95%) 0.00%
Free cash flow margin 0.00% (10.99%) 0.00%
Return on equity 0.00% (23.77%) (0.40%)
Return on assets 0.00% (6.80%) (3.32%)
Return on invested capital 0.00% (5.89%) 0.00%

Growth

Metric BGM DERM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 20.89% 10.01%
EPS growth (last fiscal year) 10.00% 34.72% 49.06%
Revenue growth, 5-year CAGR (5.39%) 6.79% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM DERM Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.79 0.05
Current ratio 1.25 1.59 2.31
Net debt to EBITDA 0.97 (0.35) 0.97

Dividend

Metric BGM DERM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric BGM DERM Drug Manufacturers Specialty & Generic median
Market cap 114.71m 144.65m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack